1. The European Parliament and the Council of the European Union (2004) Regulation (EC) N° 726/2004. Offic J Eur Union L136:1–33
2. European Council (1989) Transparency Dir. 89/105/EEC. Offic J Eur Union L40:65–71
3. Eichler HG, Bloechl-Daum B, Abadie E et al (2010) Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discovery 9:277–291
4. Kleijnen S, George E, Goulden S et al (2012) Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions. Value Health 15:954–960. doi: 10.1016/jval.2012.04.10
5. le Polain M, Franken M, Koopmanschap M et al. (2013) Drug reimbursement systems: international comparison and policy recommendations. KCE Reports 147C 2011. Available at: https://kce.fgov.be/publication/report/drug-reimbursement-systems-international-comparison-and-policy-recommendations-0 . Accessed 8 May 2013